Top Suppliers:I want be here

2460055-10-9

2460055-10-9 structure
2460055-10-9 structure
  • Name: FOXO4-DRI
  • Chemical Name: FOXO4-DRI
  • CAS Number: 2460055-10-9
  • Molecular Formula: C228H388N86O64
  • Molecular Weight: 5358.06
  • Catalog: Signaling Pathways Apoptosis Apoptosis
  • Create Date: 2023-04-20 12:44:21
  • Modify Date: 2025-08-22 19:10:37
  • FOXO4-DRI is a cell-permeable peptide antagonist that blocks the interaction of FOXO4 and p53. FOXO4-DRI is a senolytic peptide that induces apoptosis of senescent cells[1].

Name FOXO4-DRI
Description FOXO4-DRI is a cell-permeable peptide antagonist that blocks the interaction of FOXO4 and p53. FOXO4-DRI is a senolytic peptide that induces apoptosis of senescent cells[1].
Related Catalog
In Vitro FOXO4-DRI (25 mM; 3 days) 引起活性 p53 的核排斥,诱导衰老 TM3 Leydig 细胞凋亡[1]。 FOXO4-DRI (25 μM; 5 days) 显著降低 PDL9 细胞的衰老水平[2]。 Cell Viability Assay[1] Cell Line: Senescent Leydig cells Concentration: 25 mM Incubation Time: 3 days Result: Reduced the viability of senescent as compared to normal TM3 Leydig cells. Apoptosis Analysis[1] Cell Line: Senescent Leydig cells Concentration: 25 mM Incubation Time: 3 days Result: The apoptosis rate increased from 10% to 27%. Western Blot Analysis[2] Cell Line: PDL9 cells Concentration: 25 μM Incubation Time: 5 days Result: Decreased the protein levels of representative senescent markers, including p16, p21, and p53. RT-PCR[2] Cell Line: PDL9 cells Concentration: 25 μM Incubation Time: 5 days Result: Enhanced SOX9 expression, and reduced MMP12 and MMP13 expression.
In Vivo FOXO4-DRI (5 mg/kg; i.p.; every other day for three administrations) 缓解自然衰老小鼠睾丸激素分泌不足,改善睾丸微环境[1]。 Animal Model: Naturally aged male C57BL/6 mice (20-24 months old)[1] Dosage: 5 mg/kg Administration: Intraperitoneal injection, every other day for three administrations Result: Increased serum testosterone levels. Increased levels of both 3β-HSD and CYP11A1. Decreased interstitial SA-β-gal activity and lowered levels of senescence-associated proteins p53, p21, and p16. Decreased the levels of IL-1β, IL-6 and TGF-β.
References

[1]. Zhang C, et al. FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice. Aging (Albany NY). 2020 Jan 20;12(2):1272-1284.  

[2]. Huang Y, et al. Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes. Front Bioeng Biotechnol. 2021 Apr 29;9:677576.  

Molecular Formula C228H388N86O64
Molecular Weight 5358.06
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.